Medications like liraglutide and exenatide offer weight loss and glycemic control benefits, but GLP-1s superior efficacy in reducing major adverse cardiovascular events makes it a preferred choice for high-risk obese patients
What they found wasn't collapse it was redistribution
However, the 1.2 mg and 1.8 mg daily doses of liraglutide injection provided adequate systemic exposures over the body weight range of 40 to 160 kg evaluated in the clinical trials
Short-term (up to 4 weeks) : Brighter skin tone, better hydration, and increased energy levels Medium-term (13 months) : Reduced hyperpigmentation, more even skin tone, improved immunity, and sharper mental focus Long-term (over 3 months) : More pronounced skin brightening, anti-ageing effects, and liver health support To maintain these outcomes, patients are encouraged to: Stay hydrated by drinking 810 glasses of water daily Follow a diet rich in antioxidant-packed foods Use a broad-spectrum sunscreen (SPF 30+) every day While the improvements can be impressive, they are not permanent